Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia

Aim This post hoc analysis of a double‐blind (DB), randomized, placebo‐controlled, relapse‐prevention study evaluated the effects of paliperidone palmitate once‐every‐3‐months (PP3M) in a subpopulation of adults with early illness schizophrenia (duration ≤5 years) from a clinical trial. Methods Pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Early intervention in psychiatry 2019-06, Vol.13 (3), p.667-672
Hauptverfasser:	Bell Lynum, Karimah S., Turkoz, Ibrahim, Kim, Edward
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Adults Antipsychotic Agents - therapeutic use Antipsychotics Brief Report Brief Reports Clinical trials Double-Blind Method Drug Administration Schedule early illness Early Medical Intervention Evidence-based medicine Female Humans Male Medical diagnosis Middle Aged paliperidone palmitate Paliperidone Palmitate - administration & dosage Paliperidone Palmitate - adverse effects Patients Psychiatric Status Rating Scales Psychotropic drugs Randomization recently diagnosed relapse Schizophrenia Schizophrenia - diagnosis Schizophrenia - drug therapy Schizophrenic Psychology Secondary Prevention
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!